Dendritic Cell-Based Immunotherapy Combined with Antimony-Based Chemotherapy Cures Established Murine Visceral Leishmaniasis
- 1 June 2003
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 170 (11) , 5625-5629
Abstract
Dendritic cells (DCs) have been proposed to play a critical role as adjuvants in vaccination and immunotherapy. In this study we evaluated the combined effect of soluble Leishmania donovani Ag (SLDA)-pulsed syngeneic bone marrow-derived DC-based immunotherapy and antimony-based chemotherapy for the treatment of established murine visceral leishmaniasis. Three weekly injections of SLDA-pulsed DCs into L. donovani-infected mice reduced liver and splenic parasite burden significantly, but could not clear parasite load from these organs completely. Strikingly, the conventional antileishmanial chemotherapy (sodium antimony gluconate) along with injections of SLDA-pulsed DCs resulted in complete clearance of parasites from both these organs. Repetitive in vitro stimulation of splenocytes from uninfected or L. donovani-infected mice with SLDA-pulsed DCs led to the emergence of CD4+ T cells with characteristics of Th1 cells. Our data indicate that DC-based immunotherapy enhances the in vivo antileishmanial potential of antimony or vice versa.Keywords
This publication has 27 references indexed in Scilit:
- Programmed cell death in the unicellular protozoan parasite LeishmaniaCell Death & Differentiation, 2002
- Dendritic Cell-Based Vaccination Strategies: Induction of Protective Immunity against LeishmaniasisImmunobiology, 2001
- Roles of Endogenous Gamma Interferon and Macrophage Microbicidal Mechanisms in Host Response to Chemotherapy in Experimental Visceral LeishmaniasisInfection and Immunity, 2000
- Miltefosine, an Oral Agent, for the Treatment of Indian Visceral LeishmaniasisNew England Journal of Medicine, 1999
- Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin B-lipid complexPathogens and Global Health, 1998
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.Journal of Experimental Medicine, 1992
- Immunochemotherapy for Intracellular Leishmania donovani Infection: Interferon Plus Pentavalent AntimonyThe Journal of Infectious Diseases, 1988
- An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovaniJournal of Antimicrobial Chemotherapy, 1984
- IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICEJournal of Experimental Medicine, 1973
- An Eight‐day Method for Screening Compounds against Leishmania donovani in the Golden Hamster*The Journal of Protozoology, 1958